Skip to main content
    C

    Climb Bio Inc (CLYM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.78
    -0.16 (-1.61%)

    Market Cap: $583.86M

    Last updated: Nov 17, 2026 at 4:29 PM ET

    Climb Bio Inc (CLYM) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Climb Bio (CLYM) has a latest price of $9.78 on Nov 17, 2026, 46.6% below its 52-week high of $18.33. Its price rose 414.7% over the past 12 months. The month-end price fell 41.2% over the 5 years through Oct 2026, a compound annual decline of 10.1%.

    Price Chart

    From Aug 2021 to Oct 2026, its highest month-end close was $25.69 in Aug 2021 and its lowest $1.18 in May 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CLYM with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CLYM.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 43.6%, and over 6 months it rose 1.3%. The month-end price rose 289.7% over the 3 years through Oct 2026, a compound annual rate of 57.4%.

    PeriodChange
    1 month+0.5%
    3 months-43.6%
    6 months+1.3%
    12 months+414.7%
    12 months, with dividends+414.7%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+289.7%+57.4%
    5 years-41.2%-10.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 122.2%, and its weakest was 2022, when it fell 64.9%.

    YearCloseChange
    2026 through Oct 2026$10.25+156.3%
    2025$4.00+122.2%
    2024$1.80-33.3%
    2023$2.70-26.4%
    2022$3.67-64.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 13.8% below its 50-day average of $11.34 and 8.8% below its 200-day average of $10.72.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$9.78
    52-week high$18.33-46.6%
    52-week low$1.64+498.2%
    50-day average$11.34-13.8%
    200-day average$10.72-8.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 88.9%.

    MeasureValue
    1-year beta1.58
    Largest fall, 1 year-50.6%
    Largest fall, 3 years-88.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CLYM

    What is CLYM's 1-year price change?

    Climb Bio's price rose 414.7% over the past 12 months. With dividends included, the 12-month total return was 414.7%.

    What is CLYM's 5-year price change?

    Climb Bio's month-end price fell 41.2% over the 5 years through Oct 2026, a compound annual decline of 10.1%. These figures leave out dividends.

    What is CLYM's 52-week high and low?

    Climb Bio's 52-week high is $18.33 and its 52-week low is $1.64. Its latest price of $9.78 on Nov 17, 2026 is 46.6% below the high.

    What is CLYM's beta?

    Climb Bio's 1-year beta against the S&P 500 is 1.58, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 50.6%.

    Is the CLYM chart free?

    Yes. Advanced Charting for CLYM is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.